Contemporary challenges in the design of topoisomerase II inhibitors for cancer chemotherapy

C Bailly - Chemical reviews, 2012 - ACS Publications
1. INTRODUCTION The length of straightened-out DNA in a single cell is nearly 2 m. In
mammalian cells, the nucleus has a diameter of approximately 6 μm and occupies about …

Acridine and acridone derivatives, anticancer properties and synthetic methods: where are we now?

P Belmont, J Bosson, T Godet… - Anti-Cancer Agents in …, 2007 - ingentaconnect.com
Acridine derivatives are interesting chemotherapeutic agents that were first used as
antibacterial and antiparasite agents. In this review we wish to concentrate our attention on …

Natural and synthetic acridines/acridones as antitumor agents: their biological activities and methods of synthesis

G Cholewiński, K Dzierzbicka, AM Kołodziejczyk - Pharmacological reports, 2011 - Elsevier
Acridine derivatives constitute a class of compounds that are being intensively studied as
potential anticancer drugs. Acridines are well-known for their high cytotoxic activity; …

Natural compounds as anticancer agents targeting DNA topoisomerases

C Kumar Jain, H Kumar Majumder… - Current …, 2017 - ingentaconnect.com
DNA topoisomerases are important cellular enzymes found in almost all types of living cells
(eukaryotic and prokaryotic). These enzymes are essential for various DNA metabolic …

Synthesis of novel cytotoxic tetracyclic acridone derivatives and study of their molecular docking, ADMET, QSAR, bioactivity and protein binding properties

R Veligeti, RB Madhu, J Anireddy, VR Pasupuleti… - Scientific Reports, 2020 - nature.com
Acridone based synthetic and natural products with inherent anticancer activity advancing
the research and generating a large number of structurally diversified compounds. In this …

Acridine/acridone: a simple scaffold with a wide range of application in oncology

P Belmont, I Dorange - Expert Opinion on Therapeutic Patents, 2008 - Taylor & Francis
Background: The acridine scaffold is of interest since its DNA affinity and intercalative
properties make it an important pharmacophore for the design of antitumor drugs targeting …

'Acridines' as new horizons in antifungal treatment

I Gabriel - Molecules, 2020 - mdpi.com
Frequent fungal infections in immunocompromised patients and mortality due to invasive
mycosis are important clinical problems. Opportunistic pathogenic Candida species remain …

Targeting DNA topoisomerase II in antifungal chemotherapy

K Kondaka, I Gabriel - Molecules, 2022 - mdpi.com
Topoisomerase inhibitors have been in use clinically for the treatment of several diseases
for decades. Although those enzymes are significant molecular targets in antibacterial and …

Synthesis, cytotoxic study and docking based multidrug resistance modulator potential analysis of 2-(9-oxoacridin-10 (9H)-yl)-N-phenyl acetamides

R Kumar, M Kaur, MS Bahia, O Silakari - European Journal of Medicinal …, 2014 - Elsevier
The present study describes the synthesis of fifteen 2-(9-oxoacridin-10 (9H)-yl)-N-phenyl
acetamide derivatives (13a–o) through condensation of 2-chloro-N-phenyl acetamides (12a …

Metabolic profiles of new unsymmetrical bisacridine antitumor agents in electrochemical and enzymatic noncellular systems and in tumor cells

A Mieszkowska, AM Nowicka, A Kowalczyk, A Potęga… - Pharmaceuticals, 2021 - mdpi.com
New unsymmetrical bisacridines (UAs) demonstrated high activity not only against a set of
tumor cell lines but also against human tumor xenografts in nude mice. Representative UA …